Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Sagami Rubber Industries Co., Ltd. (5194.T)
Atsugi, JP
Sagami Rubber Industries Co., Ltd. is principally involved in the manufacture and supply of condoms. The company's product line features polyurethane and latex-based condoms, alongside external catheters, probe covers, plastic films, and a variety of healthcare goods and services. Its merchandise is distributed across numerous global markets, including Japan, France, Switzerland, Italy, Portugal, Spain, Finland, Norway, Sweden, Korea, Vietnam, Mexico, and the United States. Founded in 1934, the firm's corporate headquarters are located in Atsugi, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.62% | -3.44% | -9.15% | -5.70% | -18.56% | -11.03% | -24.65% | -16.23% | -38.45% | -3.15% | +45.27% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+3.9% ★ Q1'26: +9.4% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%-27.8% Q1'26: +326.3% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%-0.1% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+3.1% Q1'26: -1.0% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+0.7% Q1'26: -0.3% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+0.0% Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×5.82× Q1'26: 7.15× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
|---|---|---|---|---|---|---|---|
| Revenue |
6.26B
est: 6.30B (-0.7%)
|
6.56B
est: 6.62B (-0.9%)
|
5.59B
est: 5.58B (+0.1%)
|
5.41B
est: 5.47B (-1.0%)
|
5.98B
est: 5.40B (+10.8%)
|
6.11B
est: 5.80B (+5.4%)
|
5.69B
est: 6.20B (-8.3%)
|
| EBITDA |
1.41B
est: 1.72B (-18.2%)
|
1.84B
est: 1.81B (+1.4%)
|
1.46B
est: 1.53B (-4.5%)
|
2.00B
est: 1.50B (+33.6%)
|
1.75B
est: 1.48B (+18.6%)
|
1.14B
est: 1.59B (-28.0%)
|
1.47B
est: 1.56B (-6.0%)
|
| EBIT |
984.55M
est: 1.09B (-9.7%)
|
1.38B
est: 1.15B (+20.8%)
|
1.03B
est: 966.13M (+6.8%)
|
1.50B
est: 947.09M (+58.6%)
|
1.14B
est: 934.97M (+21.9%)
|
484.70M
est: 1.00B (-51.7%)
|
761.19M
est: 882.32M (-13.7%)
|
| Net Income |
553.12M
est: 689.38M (-19.8%)
|
902.32M
est: 750.18M (+20.3%)
|
598.05M
est: 529.79M (+12.9%)
|
1.10B
est: 859.83M (+27.7%)
|
673.52M
est: 399.52M (+68.6%)
|
40.96M
est: 500.48M (-91.8%)
|
392.54M
est: 569.95M (-31.1%)
|
| SGA |
1.52B
est: 1.43B (+6.1%)
|
1.48B
est: 1.50B (-1.5%)
|
1.25B
est: 1.27B (-0.9%)
|
1.15B
est: 1.24B (-7.3%)
|
1.23B
est: 1.23B (+0.5%)
|
1.39B
est: 1.32B (+5.6%)
|
1.50B
est: 1.42B (+5.9%)
|
| EPS |
50.94
est: 63.50 (-19.8%)
|
83.11
est: 69.10 (+20.3%)
|
55.08
est: 48.80 (+12.9%)
|
101.10
est: 79.20 (+27.7%)
|
62.04
est: 36.80 (+68.6%)
|
3.77
est: 46.10 (-91.8%)
|
36.16
est: 52.50 (-31.1%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-28 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-27 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-26 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-25 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-22 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-21 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-20 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-19 | B | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-18 | B | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-15 | B | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-14 | B | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-13 | B | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-12 | B | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-01 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-27 | B | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kensuke Oato | Chief Executive Officer, President & Representative Director | — | male |
| Koichi Fukuda | GM of Plastics Sales Division & Plastics Division and Director | — | male |
| Kunio Yoshida | Senior MD & Director | — | male |
| Shigeo Tadenuma | GM of Management Headquarters & Director | — | — |
| Shinji Hara | GM of Sales Division & Healthcare Division and Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 5194.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
